Zobrazeno 1 - 10
of 208
pro vyhledávání: '"RBC, Red Blood Cell"'
Publikováno v:
مجلة مركز بحوث التقنيات الاحيائية, Vol 16, Iss 2 (2022)
Several studies have directed the use of different chemicals as an antibiotics alternative that kills bacteria or may lead to stimulating the body's resistance against infections, such as organic acids that include non-protein amino acids especially
Externí odkaz:
https://doaj.org/article/fa0e481f09844bbd8faacbf9f4c02205
Autor:
Helene Guizouarn, Gregory Barshtein
Publikováno v:
Frontiers in Physiology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/5bfabcfd1e3748478125e1d8a85c3ba3
Autor:
Muhammad Saboor, Abdullah S. Mansor, Amr J Halawani, Farkad Bantun, Waleed Q. Mashlawi, Hisham I Abu-Tawil, Ali Y. Alhazmy
Publikováno v:
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences, Vol 29, Iss 1, Pp 251-254 (2022)
Saudi Journal of Biological Sciences, Vol 29, Iss 1, Pp 251-254 (2022)
Background The patients who require transfusion are prevalent in the Jazan Province, Saudi Arabia. Therefore, it is essential to know the frequency of blood group antigens in such a population. The Kidd blood group system (JK) has two antithetical an
Publikováno v:
Journal of Advanced Research
Graphical abstract
Introduction Neomenthol, a cyclic monoterpenoid, is a stereoisomer of menthol present in the essential oil of Mentha spp. It is used in food as a flavoring agent, in cosmetics and medicines because of its cooling effects. Howe
Introduction Neomenthol, a cyclic monoterpenoid, is a stereoisomer of menthol present in the essential oil of Mentha spp. It is used in food as a flavoring agent, in cosmetics and medicines because of its cooling effects. Howe
Autor:
G. Wikman, Anna Balyan, Kristina Jamalyan, Anders Barth, Staffan Palm, Alexander Panossian, Mikayel Narimanyan
Publikováno v:
Journal of Traditional and Complementary Medicine, Vol 11, Iss 6, Pp 552-562 (2021)
Journal of Traditional and Complementary Medicine
Journal of Traditional and Complementary Medicine
Background and aim Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, called Kan Jang®, are traditionally used for relieving symptoms of upper-respiratory tract infections (URTIs). This study aimed to as
Autor:
Thomas J. Breen, Courtney Bennett, Sean van Diepen, Jacob C. Jentzer, Nandan S. Anavekar, Malcolm R. Bell, Joseph G. Murphy, Jason N. Katz, Gregory W. Barsness
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 5, Pp 839-850 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective To determine whether the Mayo Cardiac Intensive Care Unit (CICU) Admission Risk Score (M-CARS) is associated with CICU resource utilization. Patients and Methods Adult patients admitted to our CICU from 2007 to 2018 were retrospectively rev
Autor:
Robert Sinclair, Yitian Zeng, Gentaro Ikeda, Ji Hye Jung, Christine Wahlquist, Utkan Demirci, Yunshin Jung, Nathan Bayardo, Adrian P. Gee, Connor O'Brien, Zewen Jiang, Katrin J. Svensson, Elizabeth S. Egan, Evgeniya Vaskova, Michelle R. Santoso, Phillip C. Yang, Ronald M. Witteles, Mark Mercola, Mehmet Ozgun Ozen, Liye Shi
Publikováno v:
JACC: CardioOncology
Background Anthracycline-induced cardiomyopathy (AIC) is a significant source of morbidity and mortality in cancer survivors. The role of mesenchymal stem cells (MSCs) in treating AIC was evaluated in the SENECA trial, a Phase 1 National Heart, Lung,
Publikováno v:
JAAD Case Reports
JAAD Case Reports, Vol 6, Iss 10, Pp 1065-1068 (2020)
JAAD Case Reports, Vol 6, Iss 10, Pp 1065-1068 (2020)
Autor:
Liang Han, Chen Jiang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2306-2325 (2021)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Blood–brain barrier (BBB) strictly controls matter exchange between blood and brain, and severely limits brain penetration of systemically administered drugs, resulting in ineffective drug therapy of brain diseases. However, during the onset and pr
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 12, Iss 1, Pp 92-106 (2022)
Acta Pharmaceutica Sinica B, Vol 12, Iss 1, Pp 92-106 (2022)
Nanoparticulate drug delivery systems (Nano-DDSs) have emerged as possible solution to the obstacles of anticancer drug delivery. However, the clinical outcomes and translation are restricted by several drawbacks, such as low drug loading, premature